HomeCompareRMD vs MCHP

RMD vs MCHP: Dividend Comparison 2026

RMD yields 1.06% · MCHP yields 3.03%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCHP wins by $436.15M in total portfolio value
10 years
RMD
RMD
● Live price
1.06%
Share price
$220.03
Annual div
$2.33
5Y div CAGR
35.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.7K
Annual income
$3,288.25
Full RMD calculator →
MCHP
MCHP
● Live price
3.03%
Share price
$60.06
Annual div
$1.82
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$436.18M
Annual income
$410,174,962.43
Full MCHP calculator →

Portfolio growth — RMD vs MCHP

📍 MCHP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMDMCHP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMD + MCHP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMD pays
MCHP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMD
Annual income on $10K today (after 15% tax)
$90.01/yr
After 10yr DRIP, annual income (after tax)
$2,795.01/yr
MCHP
Annual income on $10K today (after 15% tax)
$257.58/yr
After 10yr DRIP, annual income (after tax)
$348,648,718.07/yr
At 15% tax rate, MCHP beats the other by $348,645,923.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMD + MCHP for your $10,000?

RMD: 50%MCHP: 50%
100% MCHP50/50100% RMD
Portfolio after 10yr
$218.10M
Annual income
$205,089,125.33/yr
Blended yield
94.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCHP right now

RMD
Analyst Ratings
16
Buy
14
Hold
5
Sell
Consensus: Buy
Price Target
$295.88
+34.5% upside vs current
Range: $265.00 — $345.00
Altman Z
11.6
Piotroski
7/9
MCHP
Analyst Ratings
2
Strong
30
Buy
14
Hold
Consensus: Buy
Price Target
$87.00
+44.9% upside vs current
Range: $69.00 — $100.00
Altman Z
3.5
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMD buys
0
MCHP buys
0
No recent congressional trades found for RMD or MCHP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMDMCHP
Forward yield1.06%3.03%
Annual dividend / share$2.33$1.82
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.9%100%
Portfolio after 10y$31.7K$436.18M
Annual income after 10y$3,288.25$410,174,962.43
Total dividends collected$10.4K$434.25M
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusBuyBuy
Analyst price target$295.88$87.00

Year-by-year: RMD vs MCHP ($10,000, DRIP)

YearRMD PortfolioRMD Income/yrMCHP PortfolioMCHP Income/yrGap
1← crossover$10,844$143.91$11,306$606.06$462.00MCHP
2$11,801$198.21$13,378$1,280.78$1.6KMCHP
3$12,901$273.96$17,147$2,832.75$4.2KMCHP
4$14,185$380.39$25,134$6,786.65$10.9KMCHP
5$15,709$531.20$45,488$18,593.90$29.8KMCHP
6$17,556$747.16$111,571$62,898.72$94.0KMCHP
7$19,845$1,060.53$407,746$288,365.50$387.9KMCHP
8$22,757$1,522.63$2,406,121$1,969,832.89$2.38MMCHP
9$26,567$2,217.64$24,301,727$21,727,176.85$24.28MMCHP
10$31,715$3,288.25$436,177,810$410,174,962.43$436.15MMCHP

RMD vs MCHP: Complete Analysis 2026

RMDHealthcare

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Full RMD Calculator →

MCHPTechnology

Microchip Technology Incorporated develops, manufactures, and sells smart, connected, and secure embedded control solutions in the Americas, Europe, and Asia. The company offers general purpose 8-bit, 16-bit, and 32-bit microcontrollers; 32-bit embedded microprocessors markets; and specialized microcontrollers for automotive, industrial, computing, communications, lighting, power supplies, motor control, human machine interface, security, wired connectivity, and wireless connectivity applications. It also provides development tools that enable system designers to program microcontroller and microprocessor products for specific applications; field-programmable gate array (FPGA) products; and analog, interface, mixed signal, and timing products comprising power management, linear, mixed-signal, high-voltage, thermal management, discrete diodes and metal oxide semiconductor field effect transistors (MOSFETS), radio frequency (RF), drivers, safety, security, timing, USB, Ethernet, wireless, and other interface products. In addition, the company offers memory products consisting of serial electrically erasable programmable read-only memory, serial flash memories, parallel flash memories, serial static random access memories, and serial electrically erasable random access memories for the production of very small footprint devices; and licenses its SuperFlash embedded flash and NVM technologies to foundries, integrated device manufacturers, and design partners for use in the manufacture of microcontroller products, gate array, RF, analog, and neuromorphic compute products that require embedded non-volatile memory, as well as provides engineering services. Further, it offers wafer foundry and assembly, and test subcontracting manufacturing services; and timing systems products, application specific integrated circuits, and aerospace products. Microchip Technology Incorporated was incorporated in 1989 and is headquartered in Chandler, Arizona.

Full MCHP Calculator →
📬

Get this RMD vs MCHP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMD vs SCHDRMD vs JEPIRMD vs ORMD vs KORMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.